Loading...

Cardiol Therapeutics Inc.

CRDL.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$1.62
CA$0.00(0.00%)

Cardiol Therapeutics Inc. (CRDL.TO) Stock Competitors & Peer Comparison

See (CRDL.TO) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CRDL.TOCA$1.62+0.00%133.9M-3.38-CA$0.48N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$10.38-0.48%3.8B28.83CA$0.36N/A
CURA.TOCA$3.90-1.27%3B-7.96-CA$0.49N/A
GTII.CNCA$11.57-2.61%2.7B77.13CA$0.15N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$11.03+0.27%1.9B-9.85-CA$1.12N/A
TLRY.TOCA$1.59+2.58%1.7B-0.47-CA$3.40N/A
CRON.TOCA$3.61+1.69%1.4B51.57CA$0.07N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CRDL.TO vs CURA.CN Comparison August 2025

CRDL.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CRDL.TO stands at 133.9M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, CRDL.TO is priced at CA$1.62, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CRDL.TO currently has a P/E ratio of -3.38, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, CRDL.TO's ROE is -2.10%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, CRDL.TO is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for CRDL.TO.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;